69 research outputs found
Mass Spectrometry for Identification, Monitoring, and Minimal Residual Disease Detection of M-Proteins
Get PDFBACKGROUND: Monoclonal gammopathies (MGs) are plasma cell disorders defined by the clonal expansion of plasma cells, resulting in the characteristic excretion of a monoclonal immunoglobulin (M-protein). M-protein detection and quantification are integral parts of the diagnosi
MASS SPECTROMETRY AS A TOOL FOR MINIMAL RESIDUAL DISEASE DETECTION IN THE BLOOD OF MYELOMA PATIENTS
No full textTowards immunotherapy in pediatric cancer patients.
Get PDFContains fulltext :
74418.pdf (publisher's version ) (Open Access)RU Radboud Universiteit Nijmegen, 25 juni 2009Promotores : Hoogerbrugge, P.M., Adema, G.J.
Co-promotor : Vries, I.J.M. de172 p
In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study
No full textStandardization and harmonization of autoimmune diagnostics
No full textItem does not contain fulltex
The role of FcRn in the pharmacokinetics of biologics in patients with multiple myeloma
No full textItem does not contain fulltex
Detecting only light chains, now what?
No full textContains fulltext :
88361.pdf (publisher's version ) (Closed access)1 augustus 201
Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer
No full textExternal quality assessment of M-protein diagnostics: a realistic impression of the accuracy and precision of M-protein quantification
No full textItem does not contain fulltex
Reply to "Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment".
No full text- …
